ANTICOAGULANT SODIUM CITRATE
NDC 0338-9669, trisodium citrate dihydrate, solution, from Baxter Healthcare Corporation.
- Product NDC
- 0338-9669
- Status
- Listed
- Labeler
- Baxter Healthcare Corporation
- Dosage form
- SOLUTION
- Route
- EXTRACORPOREAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- BN980123
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0338-9669 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TRISODIUM CITRATE DIHYDRATE40 mg/mL
Pharmacologic classes
Acidifying Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Decreased Coagulation Factor Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0338-9669-01 | 00338966901 | 250 mL in 1 BAG (0338-9669-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/7025a0f9-1a56-4416-a3a4-925d755aed90
Use it
Look up 0338-9669 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0338-9669 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0338-9669. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.